Sugammadex vs Placebo to Prevent Residual Neuromuscular Block

NCT02728726 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

260

Enrollment

OTHER

Sponsor class

Conditions

General Surgery

Interventions

DRUG: Sugammadex
DRUG: Placebo

Sponsor

Mayo Clinic

Collaborators

[object Object]
[object Object]
[object Object]